Drug Interaction Report
3 potential interactions and/or warnings found for the following 2 drugs:
- benoxinate ophthalmic
- E S P (erythromycin / sulfisoxazole)
Interactions between your drugs
sulfiSOXAZOLE benoxinate ophthalmic
Applies to: E S P (erythromycin / sulfisoxazole), benoxinate ophthalmic
Ask your doctor before using benoxinate ophthalmic together with sulfiSOXAZOLE. Benoxinate ophthalmic may decrease the effects of sulfiSOXAZOLE. Ask your doctor to consider an alternative to benoxinate ophthalmic. If your doctor prescribes these medications together, you may need a dose adjustment to safely use both medications. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Drug and food interactions
erythromycin food
Applies to: E S P (erythromycin / sulfisoxazole)
Food decreases the levels of erythromycin in your body. Take erythromycin on an empty stomach at least 30 minutes before or 2 hours after a meal. This will make it easier for your body to absorb the medication. However, some erythromycin products may be taken without regard to meals. Ask your healthcare provider about your particular prescription if you are uncertain of how to take it. Grapefruits and grapefruit juice may increase erythromycin levels but how this may affect you is not known. Do not increase or decrease the amount of grapefruit products in your diet without first talking to your doctor.
erythromycin food
Applies to: E S P (erythromycin / sulfisoxazole)
Information for this minor interaction is available on the professional version.
Therapeutic duplication warnings
No duplication warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Akten
Akten is an ocular anesthetic for use in ocular procedures that require a topical anesthetic agent ...
Taltz
Taltz (ixekizumab) is used to treat plaque psoriasis, psoriatic arthritis, and ankylosing ...
Proparacaine ophthalmic
Proparacaine ophthalmic is used for ophthalmic surgery
Lidocaine ophthalmic
Lidocaine ophthalmic is used for local anesthesia, ophthalmic surgery
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.